Racura Oncology Ltd (ASX:RAC)

Racura Oncology Revenue

Racura Oncology had revenue of 3.05M AUD in the half year ending December 31, 2025, a decrease of -23.78%. This brings the company's revenue in the last twelve months to 3.48M, down -46.10% year-over-year. In the fiscal year ending June 30, 2025, Racura Oncology had annual revenue of 6.04M with 24.96% growth.

• Revenue (ttm): 3.48M
• Revenue Growth: -46.10%
• P/S Ratio: 124.41
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 432.54M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	6.04M	1.21M	24.96%
Jun 30, 2024	4.84M	1.70M	54.29%
Jun 30, 2023	3.13M	2.43M	342.83%
Jun 30, 2022	707.81K	320.42K	82.71%
Jun 30, 2021	387.39K	228.01K	143.07%